Washburn Theodore James Jr. - Net Worth and Insider Trading
Washburn Theodore James Jr. Net Worth
The estimated net worth of Washburn Theodore James Jr. is at least $151,121 dollars as of 2024-04-28. Washburn Theodore James Jr. is the Principal Accounting Officer of Agios Pharmaceuticals Inc and owns about 4,799 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $151,121. Details can be seen in Washburn Theodore James Jr.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Washburn Theodore James Jr. has not made any transactions after 2024-03-05 and currently still holds the listed stock(s).
Transaction Summary of Washburn Theodore James Jr.
Washburn Theodore James Jr. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Washburn Theodore James Jr. owns 1 companies in total, including Agios Pharmaceuticals Inc (AGIO) .
Click here to see the complete history of Washburn Theodore James Jr.’s form 4 insider trades.
Insider Ownership Summary of Washburn Theodore James Jr.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 2024-03-05 | Principal Accounting Officer |
Washburn Theodore James Jr. Latest Holdings Summary
Washburn Theodore James Jr. currently owns a total of 1 stock. Washburn Theodore James Jr. owns 4,799 shares of Agios Pharmaceuticals Inc (AGIO) as of March 5, 2024, with a value of $151,121.
Latest Holdings of Washburn Theodore James Jr.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 2024-03-05 | 4,799 | 31.49 | 151,121 |
Holding Weightings of Washburn Theodore James Jr.
Washburn Theodore James Jr. Form 4 Trading Tracker
According to the SEC Form 4 filings, Washburn Theodore James Jr. has made a total of 11 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 1,214 shares on March 5, 2024, which brought Washburn Theodore James Jr. around $39,540.
Insider Trading History of Washburn Theodore James Jr.
- 1
Washburn Theodore James Jr. Trading Performance
Washburn Theodore James Jr. Ownership Network
Ownership Network List of Washburn Theodore James Jr.
Ownership Network Relation of Washburn Theodore James Jr.
Washburn Theodore James Jr. Owned Company Details
What does Agios Pharmaceuticals Inc do?
Who are the key executives at Agios Pharmaceuticals Inc?
Washburn Theodore James Jr. is the Principal Accounting Officer of Agios Pharmaceuticals Inc. Other key executives at Agios Pharmaceuticals Inc include Chief Legal Officer James William Burns , Chief Medical Officer Sarah Gheuens , and director & 10 percent owner & Chief Executive Officer David P Schenkein .
Agios Pharmaceuticals Inc (AGIO) Insider Trades Summary
Over the past 18 months, Washburn Theodore James Jr. made 8 insider transaction in Agios Pharmaceuticals Inc (AGIO) with a net sale of 8,791. Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 205,692 shares made by David P Schenkein , a net sale of 14,160 shares made by James William Burns , and a net sale of 8,488 shares made by Sarah Gheuens .
In summary, during the past 3 months, insiders sold 93,495 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 93,495 shares. During the past 18 months, 358,881 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 358,881 shares.
Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agios Pharmaceuticals Inc Insider Transactions
Washburn Theodore James Jr. Mailing Address
Above is the net worth, insider trading, and ownership report for Washburn Theodore James Jr.. You might contact Washburn Theodore James Jr. via mailing address: C/o Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
